)
)
Tyme Investor Relations Material
Latest events
Q3 2022
Tyme
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Tyme Technologies Inc
Access all reports
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) for patients with a broad range of cancers. The company is developing THOR, a synthetic retinoid prodrug designed to be an orally active anticancer agent in the treatment of cancers. It offers Thymidylate synthase (TYMS) inhibitors and other chemicals used in research. The company has clinical stage product candidates under clinical development and preclinical stage programs under nonclinical development.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
TYME
Country
🇺🇸 United States